Dr. Landman is the chair of the Department of Urology at UC Irvine. He possesses extensive clinical expertise in endoscopic and laparoscopic kidney surgery, and his research has provided patients with more precise treatment.
- Dr. Landman is considered an international expert in the management of kidney cancer
- He is a pioneer on the application of minimally invasive techniques for ablation of kidney cancer
- He has helped to re-define the diagnosis of kidney cancer through the development of novel diagnostic biopsy techniques
Dr. Landman developed and tested ablation devices that are now used for minimally invasive ablation of renal tumors and malignancies. His research allowed him to pioneer the combined antegrade and retrograde approach for treatment of complex kidney stones. He is actively working on tumor markers for urologic cancers and the relationship between kidney cancer and surrounding tissues.
Dr. Landman graduated from the University of Michigan and went on to obtain his medical degree at the Columbia College of Physicians and Surgeons. His residency was completed at the Mt. Sinai School of Medicine, and his fellowship at the Washington University Division of Urology. He has served as the chair of the Department of Urology since January 2011 and was previously a director of minimally invasive urology in the Department of Urology at Columbia University College of Physicians and Surgeons in New York.
Roles & Memberships:
Dr. Landman directs the course on management of small renal tumors at the annual meeting of the American Urological Association, as well as the small renal mass mini-fellowship at UC Irvine. He is respected as an international expert in the management of kidney cancer.
Undergraduate: University of Michigan (Honors College)
Medical School: Columbia College of Physicians and Surgeons
Residency: Mt. Sinai School of Medicine
Fellowship Training: Washington University Division of Urology